USANA Health Sciences Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
USANA Health Sciences, Inc. income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Jan 2022Jan 2021Dec 2019Dec 2018
Revenue & Gross Profit
Revenue0.850.921.001.191.131.061.19
Cost of Revenue0.160.180.190.220.210.190.20
Gross Profit0.690.740.800.970.930.870.99
Operating Expenses
Research & Development0.010.010.010.010.010.010.00
Selling, General & Administrative0.260.260.260.800.750.270.28
Operating Expenses0.630.650.700.800.750.730.80
Operating Income0.070.090.110.170.180.150.19
Other Income/Expense
Interest Income0.010.010.000.000.000.000.00
Interest Expense0.000.000.000.000.000.000.00
Other Income/Expense0.000.000.000.000.000.000.00
Income
Income Before Tax0.080.100.110.170.180.150.19
Income Tax Expense0.030.040.040.050.050.050.07
Net Income0.040.060.070.120.120.100.13
Net Income - Continuous Operations0.040.060.070.120.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA0.100.120.130.180.190.170.21
EBIT0.080.100.110.170.180.150.19
Depreciation & Amortization0.020.020.010.010.010.010.00
Earnings Per Share
Basic EPS2.003.004.006.006.004.005.00
Diluted EPS2.003.004.006.006.004.005.00
Basic Shares Outstanding0.020.020.020.020.020.020.02
Diluted Shares Outstanding0.020.020.020.020.020.020.02